
|Videos|July 17, 2015
The Finish Line for Provider Status
Stephen F. Eckel, PharmD, MHA, Pharmacy Times Health-System Edition editor, defines what he thinks is the finish line of the provider status movement.
Advertisement
Stephen F. Eckel, PharmD, MHA, Pharmacy Times Health-System Edition editor and associate professor at the Eshelman School of Pharmacy at the University of North Carolina, defines what he thinks is the finish line of the provider status movement.
This video was recorded at APhA's Annual Meeting and Exposition in March 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
3
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5

















































































































































































































